Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @IdoAmitLab
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @IdoAmitLab
-
Prikvačeni tweet
How can we advance the development of immunotherapies? In this perspective we outline how single-cell genomics can revolutionize drug development. By
@IdoYofe together with@DahanLab now@NatureMedicine. (1/6) https://www.nature.com/articles/s41591-019-0736-4 …pic.twitter.com/ga8NNI9cKO
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
IdoAmitLab proslijedio/la je Tweet
Another approach relies on mathematical modeling for combos that address the interactions (since they're so simple, Figure
) and the goal of modulating tumor perfusion.
https://www.pnas.org/content/early/2020/01/29/1919764117 … @PNASNews by@UCYOfficial@BucknellU@harvardmed@MGHMedicine@MGH_RIpic.twitter.com/Ffs0g1mghV
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
IdoAmitLab proslijedio/la je Tweet
They didn’t tell me that this was part of the deal but it was worth it just to thank the organizershttps://twitter.com/reut_h/status/1224426952817283083 …
0:14Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
IdoAmitLab proslijedio/la je Tweet
#NGI2020 dishes will not be washed by ordinary guys!pic.twitter.com/PJPf3B97HcHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
IdoAmitLab proslijedio/la je Tweet
Our review on inflammatory memory in barrier tissues with
@ordovas_phd now out in@NatRevImmunol!https://www.nature.com/articles/s41577-019-0263-z …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
IdoAmitLab proslijedio/la je Tweet
Single-cell genomic approaches for developing the next generation of immunotherapies | Nature Medicinehttps://www.nature.com/articles/s41591-019-0736-4 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
IdoAmitLab proslijedio/la je Tweet
Perspective on single-cell genomic approaches for developing the next generation of immunotherapies by
@IdoAmitLab. https://rdcu.be/b08YZHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
IdoAmitLab proslijedio/la je Tweet
A new paper from the Spitale lab shows how mammalian cells salvage pyrimidine analogs, and describes new enzyme-small molecule pair for cell-type specific metabolic labeling of RNA https://www.nature.com/articles/s41592-019-0726-y …pic.twitter.com/Ds2AQ38nUl
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
IdoAmitLab proslijedio/la je Tweet
Immunotherapy for
#cancer needs refinement and this perspective makes a solid case that single-cell#genomics can help us get there https://www.nature.com/articles/s41591-019-0736-4 …@NatureMedicine by@IdoYofe@DahanLab@IdoAmitLab@WeizmannSciencepic.twitter.com/PWrbvOkx7R
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
IdoAmitLab proslijedio/la je Tweet
A new perspective by
@IdoYofe,@DahanLab and@IdoAmitLab on how single cell#genomics can revolutionize#immunotherapy is available online today. Read here: https://www.nature.com/articles/s41591-019-0736-4 …pic.twitter.com/zxdZEPrZux
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
IdoAmitLab proslijedio/la je Tweet
@IdoAmitLab: new protocol allows to preserve RNA+protein and can be combined with intracellular protein detection. Combine with CITE-seq and think about signaling, phosphoflow, transcription factors you will be able to measure! Will be a game-changer for multi-omics!#NGI2020Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
IdoAmitLab proslijedio/la je Tweet
Could single-cell genomic technologies hold the key to develop the next generation of
#immunotherapies? https://go.nature.com/2UnzGE2@IdoAmitLab@NatureMedicinepic.twitter.com/U40Rm3pSa2
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
In summary, we anticipate that single-cell technologies will become an essential tool for drug development in the near future, and will drive a revolution in the research and development of immunotherapies. (6/6)
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
In the perspective we outline how single-cell analysis can be used to select a mouse/organoid model system, direct antibody-engineering approaches, and compare between mono- and combination-therapy, facilitating rational design of the most effective treatment courses. (5/6)pic.twitter.com/yqGkzG1O9W
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Evaluating the function of immunotherapies by simple parameters, like tumor growth or cell type measurements, limits our ability to outline their precise mechanisms of action.
#scRNAseq resolves this, by defining the cells and pathways affected by the treatment. (4/6)Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Tumors contain a mixture of cells of different lineages and states, participating in pro/anti-tumor activities. While immunotherapies have a specific target (e.g. PD-1), they may cause diverse direct and secondary effects, leading to the anticipated response, or lack of it. (3/6)pic.twitter.com/QBq77yN1SS
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our vision is that in the coming years single-cell analysis will be fully integrated in drug development pipelines, empowering the discovery of new targets and biomarkers, enabling definition of immunotherapies’ mechanisms of action, guiding the design of clinical trials. (2/6)pic.twitter.com/YU6e0UxgXK
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
IdoAmitLab proslijedio/la je TweetHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
IdoAmitLab proslijedio/la je Tweet
Indeed, awesome projects & talk!! I may be biased though...
#NGI2020https://twitter.com/asharmaiisc/status/1224342262106161155 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
IdoAmitLab proslijedio/la je Tweet
@FGinhoux at#NGI2020 new studies on iPSC-derived resident macrophages in 3D organoids: beautiful live imaging in the organoids!!! What a mindblowing day@WeizmannScience!pic.twitter.com/SvqOcsYyA4
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.
development and disease